Phase
Condition
Prostate Cancer
Prostate Disorders
Urologic Cancer
Treatment
N/AClinical Study ID
Male
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
The interval between prostate MRI and biopsy within 3 months
Integrity of related data
Exclusion
Exclusion Criteria:
PSA less than 50ng/ml
Any treatment for PCa prior to either MRI or biopsy, including radicalprostatectomy, radiotherapy, chemotherapy, and endocrine therapy
Previous history of surgical treatment or 5α-reductase inhibitor therapy for benignprostatic hyperplasia
Subjects undergoing MRI with an indwelling urinary catheter or suprapubic catheter
Inadequate quality of MRI images
Study Design
Study Description
Connect with a study center
Peking University First Hospital
Beijing, 100034
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.